TIDMOXB

Oxford Biomedica PLC

09 November 2017

Oxford BioMedica to Present at the Jefferies 2017 London Healthcare Conference

Oxford, UK - 9 November 2017: Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and cell therapy group, today announces that John Dawson, Chief Executive Officer, will be speaking at the Jefferies 2017 London Healthcare Conference at 13:20 GMT on 15 November 2017.

- Ends -

 
 For further information, please 
  contact: 
  Oxford BioMedica plc:                      Tel: +44 (0)1865 
   John Dawson, Chief Executive Officer       783 000 
   Stuart Paynter, Chief Financial 
   Officer 
 Consilium Strategic Communications         Tel: +44 (0)20 
  Mary-Jane Elliott/Matthew Neal/Philippa    3709 5700 
  Gardner/Laura Thornton/Rosie Phillips

Notes for editors

About Oxford BioMedica

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the "Group") have built a sector leading lentiviral vector delivery platform (LentiVector(R) ), which the Group leverages to develop in vivo and ex vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. The Group has also entered into a number of partnerships, including with Novartis, Sanofi, GSK, Orchard Therapeutics and Immune Design, through which it has long-term economic interests in other potential gene and cell therapy products. Oxford BioMedica is based across several locations in Oxfordshire, UK and employs more than 280 people. Further information is available at www.oxfordbiomedica.co.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAEALFPESDXFFF

(END) Dow Jones Newswires

November 09, 2017 02:02 ET (07:02 GMT)

Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Oxford Biomedica Charts.
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Oxford Biomedica Charts.